Journal of

Obesity and Weight-loss MedicationISSN: 2572-4010

Early Online

 Open Access DOI:10.23937/2572-4010.1510031

Evaluation of Fucoxanthin Content in Popular Weight Loss Supplements: The Case for Stricter Regulation of Dietary Supplements

Mohammad Faisal Hossain, Mamoon Rashid, Thomas Burniston, Mohammed Ahmed, Winnie Wu, Kolawole Adeshina Kataye, Rajjit Sidhu, Michael Justice and Shamly Abdelfattah

Article Type: Original Research | First Published: September 05, 2019

Misbranded and counterfeit dietary supplements have been an issue on which the US Food and Drug Administration has been vigilantly regulating. The ubiquity of online- shoppable weight-loss supplements and their unrestricted consumption by obese people are serious matters of concern. Fucoxanthin, a brown-seaweed-extracted carotenoid has exhibited anti-obesity property in some clinical trials through its ability to over express uncoupling protein (UCP1) in the white adipose tissue, which leads to ...

 Open Access DOI:10.23937/2572-4010.1510030

OR-MRS Cannot be used for Morbidity in Laparoscopic Sleeve Gastrectomy

Evrim Kucur Tulubas

Article Type: Original Research | First Published: July 15, 2019

A reliable method to predict postoperative risks may improve surgical risks and ensure preventive precautions to reduce complication risks. American Society of Anesthesiologists (ASA) is a common method to determine surgical risk, but at first glance it appears to be insufficient to determine the risk of morbid obesity surgery. The greatest advantage of Obesity Surgery Mortality Risk Score (OS-MRS) is the use of five easily obtained clinical variables. A possible disadvantage is that it may only...

 Open Access DOI:10.23937/2572-4010.1510029

Use of Text Messaging as an Intervention to Promote Weight Loss and Reduce Waist Circumference among an Overweight and Abdominally Obese Patient Population: A Randomized-Controlled Quality Improvement Study in Primary Care

Deepa Iyengar, MD, MPH, Michelle R Klawans, MPH, Angela L Stotts, PhD and Thomas F Northrup, PhD

Article Type: Research Article | First Published: May 13, 2019

Obesity is a national epidemic resulting in significant morbidity and mortality. Weight loss as modest as 5% of body weight significantly reduces the risk of hypertension, diabetes, and cardiovascular disease. The primary aim of this pilot study was to test the efficacy of a text messaging intervention in a primary care setting to motivate overweight patients to lose weight and reduce their waist circumference....

 Open Access DOI:10.23937/2572-4010.1510028

BMI, Waist Size, GFR: In African American Blacks

Clive O Callender, MD, Denee T Mwendwa, PhD, Georica Gholson, PhD, Regina Sims Wright, PhD, Larry Keen II, PhD, Babwande Adesibikan, MD, Serge Madhere, PhD, Victor Apprey, PhD, George Bonney, PhD, Miriam Michael, MD, Bomi Magnus-Lawson, MD, Gabriel Ivy, MD, Linda Idris-Suleiman, MD, Arturo Hernandez, MD, Olga Herren, MS, and Alfonso L Campbell, PhD

Article Type: Research article | First Published: April 10, 2019

Blacks have a greater need for kidney transplants than other American ethnic groups. Overrepresented on kidney transplant waiting lists (13%), they account for 35% of those waiting. Recent studies show that Black live donors are at greater risk for kidney failure, (44%) after donation, compared to other ethnicities. Explanations for these live donation data are few. While diabetic, hypertensive or morbidly obese Blacks are excluded as live donors; those overweight or obese are not. Participants ...

 Open Access DOI:10.23937/2572-4010.1510027

Laparoscopic Roux-En-Y Gastric Bypass for Uncontrolled Diabetes in a Patient with Extremely Low Body Mass Index after Modified Gastric Bypass Surgery

Song-hua Zeng, Hong-bin Zhang and Liang-ping Wu

Article Type: Case Report | First Published: January 12, 2019

Laparoscopic roux-en-Y gastric bypass (LRYGB) surgery is often performed on patients with body mass index (BMI) > 35 kg/m2 in Europe and the United States. Due to the risk of malnutrition, LRYGB is not always suitable for Chinese diabetic patients, particularly for those with type 2 diabetes mellitus (T2DM), a BMI < 35 kg/m2, and when nutritional levels are not great pre-surgery. Modified gastric bypass surgery is reserved for diabetic patients with BMI < 35 kg/m2 by Chinese clinicians in order ...

 Open Access DOI:10.23937/2572-4010.1510026

Venous Thromboembolism and Bariatric Surgery in the Middle East Region

Ashraf Haddad, Ahmad Bashir, Mohamed Al Hadad, Hayssam Fawal and Abdelrahman Nimeri

Article Type: Original Research | First Published: January 12, 2019

Eighty-two surgeons (63%) responded, they performed 121,369 cases and encountered 230 VTEs (0.19%). VTEs included 13 upper extremity, 103 lower extremity, 57 pulmonary embolism (PE), and 57 porto-mesenteric venous thrombosis (PMT). There was 9 VTE related mortalities constituting 4% mortality rate. The most commonly performed procedure was Sleeve Gastrostomy (56%). It was followed by Adjustable Gastric band (13%), One Anastomosis Gastric Bypass (10%), and Roux-en-Y Gastric bypass (9%). A scoring...

 Open Access DOI:10.23937/2572-4010.1510025

Idiopathic Colitis after Bilio-Pancreatic Diversion: A Report of Two Cases and a Review of the Literature

Forat Swaid, Mustafa Somri, Simona Croitoru and Ibrahim Matter

Article Type: Case Report | First Published: January 10, 2019

Biliopancreatic diversion (BPD) is considered the most effective procedure for the surgical treatment of morbid obesity. First presented by Dr. Nicola Scopinaro in 1976, this operation proved safe and reproducible, with astonishing results regarding weight loss and weight maintenance for many years after the operation. Possible late complications include anemia, stomal ulcer, bone demineralization, neurologic complications, and protein malnutrition....

 Open Access DOI:10.23937/2572-4010.1510024

Approach to Obesity Management in the Primary Care Setting

Samuel N Grief and Megan Waterman

Article Type: Research Article | First Published: January 09, 2019

Obesity is a complex, multifactorial disease that develops from the interaction between genotype and the environment. Our understanding of how and why obesity occurs is incomplete; however, it involves the integration of social, behavioral, cultural, physiological, metabolic, and genetic factors. Genetics has been a common variable researched among scientists, and the link has been proven between genetic predisposition and likelihood of developing obesity....

Volume 5
Issue 1